TGFβ2 in rabbit blastocoelic fluid regulates CD4 membrane expression: Possible role in the success of gestation

American Journal of Reproductive Immunology

Volumn 37, Issue 1, 1997, Pages 125-136

  Ouellette, Marie Josée ^a   Dubois, Claire M ^b,c   Bergeron, Dominic ^a   Roy, Raynald ^a   Lambert, Raymond D ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Decidua; Immunosuppression; Tumor survival

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BLASTOCYTE; CELL POPULATION; CONTROLLED STUDY; DECIDUA; FEMALE; INTRACELLULAR FLUID; LYMPHOCYTE CULTURE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE;

EID: 0031049982     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00201.x     Document Type: Article

References (45)

1. Bulmer JN. Cells of immunological relevance in the human uterus during pregnancy. In Immunology of pregnancy. G Chaouat (ed). CRC Press, 1993, pp 61-78.
2. Roussev RG, Higgins NG, McIntyre JA. Phenotypic characterization of normal human placental mononuclear cells. J Reprod Immunol 1993; 25:15-29.
3. Ritson A, Bulmer JN. Endometrial granulocytes in human decidua react with a natural-killer (NK) cell marker, NKH1. Immunology 1987; 62:329-331.
4. Starkey PM, Sargent IL, Redman CWG. Cell population in human early pregnancy decidua: Characterization and isolation of large granular lymphocytes by flow cytometry. Immunology 1988; 65:129-134.
5. Morii T, Nishikawa K, Saito S, Enomoto M, Ito A, Kurai N, Shimoyama T, Ichijo M, Narita N. T cell receptors are expressed but down-regulated on intradecidual T lymphocytes. Am J Reprod Immunol 1993; 29:1-4.
6. Chao KH, Yang YS, Ho HN, Chen SU, Dai HF, Huang SC, Gill TJ. Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am J Reprod Immunol 1995; 34:274-280.
7. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991; 6:791-798.
8. Bulmer JN, Johnson PM. The T-lymphocyte population in first-trimester human decidua does not express the interleukin-2 receptor. Immunology 1986; 58:685-687.
9. Starkey PM. Expression on cells of early pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins. Immunology 1991; 73:64-70.
10. Yoshida M, Kanzaki H, Kariya M, Emi N, Imai K, Okamoto N, Uchida A, Kasakura S, Mori T. Reduction of interleukin-2-receptor expression on retroplacental blood lymphocytes in human pregnancy. Am J Reprod Immunol 1990; 22:1-3.
11. Bergeron D, Audette M, Lambert RD. Regulation of leucocyte interleukin 2 and interleukin 2 receptor gene expression by rabbit blastocoelic fluid. J Reprod Fertil 1996; 106:143-151.
12. Pandian AMC, Lambert RD, Roy R. Immunosuppressive effects of rabbit blastocoelic fluid and embryo culture medium.J Reprod Immunol 1988; 13:221-234.
13. Lambert RD, Roy R, Morin C, Beaudoin J, Langlais J, Pandian AMC. Modulation of the immunosuppressive activities by blastocoelic fluid during rabbit pregnancy. J Reprod Immunol 1989a; 15:257-268.
14. Lambert RD, Gosselin S, Pothier F, Morin C, Veilleux R, Roy M, Fortier MA. Rabbit blastocoelic fluid regulation of tumor cell proliferation in vitro. Int J Cancer 1989b; 44:524-528.
15. Lambert RD, Dufour M, Blouin L. Rabbit embryo-fetal fluid decreases the cell cycle activies of DU-145 cells. Cell Prolif 1992; 25:141-153.
16. Lapointe J, Bergeron D, Dufour M, Dubé D, Govindan MV, Lambert RD. Biochemical and morphological characterizations of DU-145 cell mortality in rabbit embryo-fetal fluid. Cell Prolif 1993; 26:125-138.
17. Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor β. Biochem Biophys Acta 1990; 1032, 79-87.
18. 2-like molecules of unusual molecular size released in bioactive form. Biol Reprod 1995; 52:1380-1388.
19. Schlafke S, Enders AC. Cellular basis of interaction between trophoblast and uterus at implantation. Biol Reprod 1975; 12:41-65.
20. Morin C, Langlais J, Lambert RD. Possible implication of lysophosphophatidylcholine in cell accompanying implantation in rabbits. J Reprod Fertil 1992; 96:827-836.
21. 125I-labeled type β transforming growth factor from human platelets. Proc Natl Acad Sci USA 1984; 81:6757-6761.
22. Dijke PT, Hansen P, Itawa KK, Pieler C, Foulkes G. Identification of another member of the transforming growth factor type β gene family. Proc Natl Acad Sci USA. 1988; 85:4715-4719.
23. Abbas AK, Lichtman AH, Pober JS: Cellular and molecular immunology. Philadelphia, Pennsylvania, WB Saunders Company, 1980.
24. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectionnal cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
25. Mosman TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-2357.
26. Cherwinsky H, Schumacher JH, Brown KD, Mosman TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionnally monospecific bioassays and monoclonal antibodies. J Exp Med 1987; 166:1229-1244.
27. Hunt JS. Immunologically relevant cells in the uterus. Biol Reprod 1994; 50:461-466.
28. Heine UI, Munoz EF, Flanders KC, Ellingsworth LR, Lam HY, Thompson NL, Roberts AB, Sporn MB. Role of transforming growth factor-β in the development of the mouse embryo. J Cell Biol 1987; 105:2861-2876.
29. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, Derynck R. Murine transforming growth factor-β2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol 1989; 3:1108-1114.
30. Doré JJE, Wilkinson JE, Godkin JD. Early gestational expression of transforming growth factor beta isoforms by ovine placenta. Biol Reprod 1995; 53:143-152.
31. Chernyshov VP, Slukvin II, Bondarenko GI. Phenotypic characterization of CD7+, CD3+ and CD8+ lymphocytes from first trimester decidua using two-color flow cytometry. Am J Reprod Immunol 1993; 29:5-16.
32. Dielt J, Horny HP, Ruck P, Marzurch K, Kaiserling E, Griesser H, Kabelitz D. Intradecidual T lymphocytes lack immunohistochemically detectable T-cell receptors. Am J Reprod Immunol 1990; 24:33-36.
33. Clark DA, Lea RG, Flanders KC, Banwatt D, Chaouat G. Role of a unique species of transforming growth factor beta in preventing rejection of the conceptus during pregnancy. Prog Immunol 1992; VIII:841-847.
34. Bry K, Hallman M. Transforming growth factor-β2 prevents preterm delivery induced by interleukin-1a and tumor necrosis factor-α in the rabbit. Am J Obstet Gynecol 1993; 168:1318-1322.
35. Gabrielian K, Osusky R, Sippy BD, Ryan SJ, Hinton DR. Effect of TGF-β on interferon-γ-induced HLA-DR expression in human retinal pigment epithelial cells. Invest Ophtalmol Vis Sci 1994; 35:4253-4259.
36. Qin L, Chavin KD, Ding Y, Favaro JP, Woodward JE, Lin J, Tahara H, Robbins P, Shaked A, Ho DY, Sapolsky RM, Lotze MT, Bromberg JS. Mutiple vectors effectively achieve gene transfer in murine cardiac transplantation model. Transplantation 1995; 59:809-816.
37. Rhee SS, Marsh JW. Human immunodeficiency virus type 1 nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol 1994; Aug:5156-5163.
38. Brady HJM, Pennington DJ, Miles CG, Dzierzak EA. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration. EMBO 1993; 13:4923-4932.
39. Navikas V, Link J, Wahren B, Persson C, Link H. Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994; 96:59-63.
40. Bodmer S, Hubert D, Heid I, Fontana A. Human glioblastoma cell derived transforming growth factor-beta 2: evidence for secretion of both high and low molecular weight biologically active forms. J Neuroimmuno 1991; 34:33-42.
41. Kopp A, Jonat W, Schmahl M, Knabbe C. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res 1995; 55:4512-4515.
42. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role or tumor cell/host TGF-β interactions in human breast cancer progression. J Clin Invest 1993; 92:2569-2576.
43. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA. A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 1990; 87:1486-1490.
44. Clark DA, Vince G, Flanders KC, Hirte H, Starkey P. CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-B2-related immunosuppressive factors. Hum Reprod 1994; 9:2270-2277.
45. Lea RG, Underwood J, Flanders KC, Hirte H, Banwatt D, Finotto S, Ohno I, Daya S, Harley C, Michel M, Mowbray JF et Clark DA. A subset of patients with recurrent spontaneous abortion is deficient in transforming growth factor B2-producing "suppressor cells" in uterine tissue near the placental attachment site. Am J Reprod Immunol 1995; 34:52-64.